EXP CODE — Daratumumab Importer Profile
Pharmaceutical Importer · #4 buyer for Daratumumab · $69.0K import value · 11 shipments · BRAZIL · DGFT Verified
EXP CODE is the #4 importer of Daratumumab from India with $69.0K in import value and 11 verified shipments. EXP CODE holds a 5.2% market share in Daratumumab imports based in BRAZIL. The company sources from 1 verified supplier across 11 formulations shipped to 1 country. Overall, EXP CODE imports 4 pharmaceutical products worth $137.5K across 2 therapeutic categories.
EXP CODE — Daratumumab Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Daratumumab to EXP CODE?
Verified from 11 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| VAMA LIFECARE PRIVATE LIMITED | $69.0K | 11 | 100.0% |
EXP CODE sources Daratumumab from 1 verified Indian supplier based on 11 customs records. The primary supplier is VAMA LIFECARE PRIVATE LIMITED accounting for 100.0% of imports.
How Does EXP CODE Compare to Nearest Daratumumab Importers?
Buyers ranked immediately above and below #4 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 2 | AS PER INVOICE AS | BRAZIL | $74.3K | 3 | $24.8K |
| 3 | TO THE CONCERN PERSON | BRAZIL | $72.5K | 10 | $7.3K |
| 4 | EXP CODE ★ | BRAZIL | $69.0K | 11 | $6.3K |
| 5 | IBL LTD-HEALTHACTIV | MAURITIUS | $55.1K | 3 | $18.4K |
| 6 | MERMISI LLC | GEORGIA | $54.0K | 8 | $6.8K |
EXP CODE ranks #4 among 56 Daratumumab importers from India. Average shipment value of $6.3K compared to the market average of $10.3K. The closest competitors by value are AS PER INVOICE AS and TO THE CONCERN PERSON.
Where Does EXP CODE Import Daratumumab To?
Destination countries from 11 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| BRAZIL | $69.0K | 11 | 100.0% |
EXP CODE imports Daratumumab to 1 country. The primary destination is BRAZIL receiving 100.0% of shipments worth $69.0K.
What Daratumumab Formulations Does EXP CODE Import?
| Formulation | Value | Shipments |
|---|---|---|
| HARMLESS MEDICINE FOR HUMAN CONSUMPTIONDARATUMUMAB CONCENTRATE FOR SOLUTION FORINFUSION 400 MG / 20 ML BATCH NO. M | $21.9K | 1 |
| HARMLESS MEDICINE FOR HUMAN CONSUMPTIONDARATUMUMAB CONCENTRATE FOR SOLUTION FORINFUSION 400MG/20ML BRAND NAME: DARZAL | $9.5K | 1 |
| HARMLESS MEDICINE FOR HUMAN CONSUMPTIONDARATUMUMAB CONCENTRATE FOR SOLUTION FORINFUSION 100 MG / 5 ML BATCH NO. MK | $8.0K | 1 |
| HARMLESS MEDICINE FOR HUMAN CONSUMPTIONDARATUMUMAB CONCENTRATE FOR SOLUTION FORINFUSION 400 MG/20ML BRAND NAME:DARZAL | $8.0K | 1 |
| HARMLESS MEDICINE FOR HUMAN CONSUMPTIONDARATUMUMAB CONCENTRATE FOR SOLUTION FORINFUSION 400 MG/20 ML BATCH NO. MKS1T0 | $7.0K | 1 |
| HARMLESS MEDICINE FOR HUMAN CONSUMPTIONDARATUMUMAB CONCENTRATE FOR SOLUTION FORINFUSION 400MG/20MLBRAND NAME:DARZALEX | $4.8K | 1 |
| HARMLESS MEDICINE FOR HUMAN CONSUMPTIONDARATUMUMAB CONCENTRATE FOR SOLUTION FORINFUSION 400 MG/20 ML BATCH NO. MSK1T0 | $2.6K | 1 |
| HARMLESS MEDICINE FOR HUMAN CONSUMPTIONDARATUMUMAB CONCENTRATE FOR SOLUTION FORINFUSION 400MG/20ML BRAND NAME: DARZALE | $2.4K | 1 |
| HARMLESS MEDICINE FOR HUMAN CONSUMPTIONDARATUMUMAB CONCENTRATE FOR SOLUTION FORINFUSION 100MG/5ML BRAND NAME: DARZALEX | $1.9K | 1 |
| HARMLESS MEDICINE FOR HUMAN CONSUMPTIONDARATUMUMAB CONCENTRATE FOR SOLUTION FORINFUSION 100MG/5MLBRAND NAME:DARZALEX | $1.9K | 1 |
EXP CODE imports 11 distinct Daratumumab formulations from India. The top formulation is HARMLESS MEDICINE FOR HUMAN CONSUMPTIONDARATUMUMAB CONCENTRA with 1 shipments worth $21.9K.
Regulatory Requirements: Importing Daratumumab into Brazil
What EXP CODE and other importers must comply with to import Daratumumab from India
Regulatory Authority
Brazilian Health Regulatory Agency (ANVISA)
Approval Process for Generic Daratumumab
Generic drug registration under RDC 200/2017. Requires pharmaceutical equivalence and bioequivalence studies. ANVISA GMP inspection of overseas facilities mandatory.
Typical timeline: 12–24 months
GMP Requirements
ANVISA GMP certificate (CBPF) for each manufacturing site; on-site inspection by ANVISA
Import Licence & Documentation
Import Authorization (LI) via SISCOMEX; Sanitary Import Permit from ANVISA
Labeling & Packaging
Portuguese language labeling mandatory; ANVISA registration number
Note: ANVISA maintains an active inspection program for Indian pharma facilities. Inspection backlog can extend timelines significantly.
Regulatory information is provided for general reference based on publicly available ANVISA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with ANVISA or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Daratumumab from India and How Much Does EXP CODE Import?
India exported $576.7K worth of Daratumumab through 209 shipments from 36 suppliers to 23 countries, serving 56 buyers globally. EXP CODE imports $69.0K of this total, accounting for 5.2% of India's Daratumumab exports with 11 shipments from BRAZIL. This is verified from 11 customs shipment records covering 11 distinct formulations.
What Is the Average Order Value for EXP CODE's Daratumumab Imports?
EXP CODE's average Daratumumab order value is $6.3K per consignment, based on 11 shipments totaling $69.0K. EXP CODE is based in BRAZIL and ranks #4 among all Daratumumab importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Daratumumab to EXP CODE?
EXP CODE sources Daratumumab from 1 verified Indian supplier: VAMA LIFECARE PRIVATE LIMITED ($69.0K, 100.0%). This is based on 11 customs records.
How Does EXP CODE Compare to Other Daratumumab Importers?
EXP CODE ranks #4 among 56 Daratumumab importers from India with a 5.2% market share. The top 3 importers are AS PER INVOICE BRAZIL ($93.8K), AS PER INVOICE AS ($74.3K), TO THE CONCERN PERSON ($72.5K). EXP CODE processed 11 shipments from BRAZIL.
What Other Advanced Oncology Products Does EXP CODE Import?
EXP CODE also imports these advanced oncology products. Each links to the detailed product page.
About EXP CODE
EXP CODE imports 4 products worth $137.5K. Beyond Daratumumab, top products include Pembrolizumab, Vinblastine, Actinomycin. View the complete EXP CODE profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Daratumumab — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Daratumumab shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: EXP CODE matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as EXP CODE's capped import value divided by total capped export value for Daratumumab across all Indian exporters.
- 5.Verified Records: This page is backed by 11 individual customs records matching EXP CODE importing Daratumumab, covering 11 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 23+ countries, 56+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Daratumumab Import Data for EXP CODE
Access order-level details, pricing data, supplier connections, and competitive analysis for EXP CODE's Daratumumab imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
EXP CODE
Full Company Profile →
4 products · $137.5K total trade · 2 categories
EXP CODE × Daratumumab
Verified from customs records
Company Overview
Top Products by EXP CODE
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for EXP CODE.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Daratumumab. For current order-level data, contact TransData Nexus.